ANATOMIC PATHOLOGY. Original Article
|
|
- Oscar McLaughlin
- 5 years ago
- Views:
Transcription
1 ANATOMIC PATHOLOGY Original Article Intraductal Carcinoma Associated With Invasive Carcinoma of the Breast A Comparison of the Two Lesions With Implications for Intraductal Carcinoma Classification Systems NEAL S. GOLDSTEIN, MD, AND TRACY MURPHY, Intraductal carcinoma (DCIS) is a useful marker for predicting which women will develop a recurrent breast malignancy. The authors examined 5 consecutive, mammographically detected, Tl invasive carcinomas associated with DCIS to study the DCIS and compare it to its associated invasive carcinoma. Intraductal carcinoma nuclear grades were assigned to each duct on a scale of to. The percentage of DCIS ducts that were involved by each grade was quantitated into quartiles for cases with more than one DCIS nuclear grade. The predominant architectural pattern corresponding to each DCIS nuclear grade was recorded. Ninety-two percent of the 5 invasive carcinomas were of ductal type, 4% were tubular, and the remainder were various other subtypes. Nine percent of the DCIS cases were nuclear grade. The remaining % of cases were almost evenly distributed between mixed DCIS nuclear grades and (%), pure DCIS nuclear grade (4%), Intraductal carcinoma, or duct carcinoma in situ (DCIS) of the breast is a lesion that has increased in importance with the development of breast-sparing therapy, because it is a useful index for helping to predict which patients will develop a recurrent malignancy, either DCIS or invasive carcinoma. It is thought that DCIS is the progenitor of invasive carcinoma, yet only a few investigators have attended to the relation between types and grade of invasive carcinoma and different forms or grades of the associated DCIS. " Although authors have documented architectural heterogeneity within a given patient's DCIS, ' 4 " 7 little attention has been giving to the degree of nuclear heterogeneity that can be present in a patient's DCIS lesion. Addressing the degree of nuclear heterogeneity within From the Department of Anatomic Pathology, William Beaumont Hospital. Royal Oak, Michigan. Manuscript received November 4, 5; revision accepted February 8, 6. Address all correspondence to Dr. Goldstein: Department of Anatomic Pathology. William Beaumont Hospital, 6 West Mile Road, Royal Oak, MI 487. MD mixed DCIS nuclear grade to (5%), and pure DCIS nuclear grade (%). Two percent of cases were a mixture of DCIS nuclear grades and or,, and. All pure DCIS nuclear grade or mixed and were associated with well or moderately differentiated invasive carcinomas, whereas the majority (6%) of the pure DCIS nuclear grade cases were associated with poorly differentiated invasive carcinomas. There was no relation between the DCIS architectural pattern and the invasive carcinoma grade. In general, the DCIS nuclear grade correlates with the grade of the invasive carcinoma. Unlike DCIS architecture, nuclear grade heterogeneity within DCIS associated with invasive carcinoma is minimal. DCIS classification systems based on nuclear grade have merit because there is little variation in nuclear grade within a given patient's lesion. (Key words: Breast; Duct carcinoma in situ; Invasive carcinoma) Am J Clin Pathol 6; 6:-8. DCIS is relevant to the ongoing debate about DCIS classifications. 7 " We examined 5 consecutive, mammographically detected, small invasive carcinomas with DCIS accessioned over the -year period -4 to study the relation between DCIS nuclear grade and architecture and composite grade of the associated invasive carcinoma, and to document the degree of nuclear and architectural heterogeneity within DCIS. MATERIALS AND METHODS One hundred fifty consecutive, mammographically detected, pathologic stage-t invasive carcinomas accessioned by the Department of Anatomic Pathology at William Beaumont Hospital during to 4 were reviewed. were identified with the assistance of the hospital Tumor Registry. All slides from all the patients' breast-related procedures were examined, including biopsies, lumpectomies, and mastectomies. The invasive carcinomas were categorized by the criteria of Page and Anderson" and graded with the Ellston and Ellis criteria. Invasive carcinomas devoid of an intraductal carcinoma component were excluded. Downloaded from by guest on November 8
2 GOLDSTEIN AND MURPHY Carcinoma FIG.. Nuclear grade duct carcinoma in situ (DCIS). Round uniform nuclei with occasional punctate nucleoli (hematoxylin and eosin, XI5). This photomicrograph demonstrates minimal nuclear variation. Although there is some heterogeneity in chromatin density between cells, none of the cells have course chromatin. Also, there is little variation in nuclear size and shape between cells. Despite the variation, all the cells are less atypical than grade DCIS. This photomicrograph was taken at X.8 lower magnification than Figures and to provide a larger field. Nuclear grades, on a scale of to, were assigned to each DCIS duct in each lesion. Grade was the lowest nuclear grade (Fig. ). The nuclei of grade DCIS were usually small with little variation in size. They had smooth nuclear membranes, uniform chromatin, and occasional punctate nucleoli. DCIS grade cells were monomorphic and were evenly spaced. Grade DCIS was composed of cells that were larger than grade DCIS cells (Fig. ). There was moderate variation of the FIG.. Nuclear grade duct carcinoma in situ (DCIS). Slightly larger nuclei than nuclear grade DCIS with moderate pleomorphism and occasional medium-sized nucleoli (hematoxylin and eosin, X). FIG.. Nuclear grade duct carcinoma in situ (DCIS). Highly atypical nuclei with extreme pleomorphism, course chromatin, and many large nucleoli (hematoxylin and eosin, XI). nuclear shape, and the nuclear membrane thickness varied slightly. The chromatin was less homogenous than in grade DCIS nuclei. Nucleoli were present in most cells, including macronucleoli. Grade DCIS cells had more size and shape variation than grade DCIS. Grade DCIS was composed of pleomorphic cells (Fig. ). There was marked variation in the size and shape of grade DCIS cells. Most nuclei were large, with nuclear membrane irregularities. Chromatin was very course and clumped, and usually there was at least one macronucleolus. The predominant nuclear grade in each duct was assigned when there was a mixture of nuclear grades within a duct. The percentage of the DCIS ducts composed of each nuclear grade was quantified into quartiles, (%, l%-5%, 6%-5%, 5%-75%, 76%-%, and %). The predominant architectural pattern and second most common architectural pattern associated with each DCIS nuclear grade were categorized as centrally necrotic, solid, cribriform, micropapillary, and clinging. For this study, centrally necrotic was used as a distinctive architectural pattern and could be formed by cells of any DCIS nuclear grade. Centrally necrotic architectural pattern was defined as a duct with a well-defined central zone of coagulative necrosis, ringed by tumor cells adherent to the duct wall. Occasional small glands within the peripheral ring of solid tumor cells were allowed within a centrally necrotic pattern and were not classified as cribriform pattern. Aside from being a mandatory constituent of the centrally necrotic architectural pattern, the presence of small to moderate amounts of necrosis within ducts was not evaluated. Downloaded from by guest on November 8 Vol. 6-No.
3 4 ANATOMIC PATHOLOGY Original Article TABLE. GRADE AND TYPE OF 5 PATHOLOGIC STAGE Tl INVASIVE CARCINOMAS Type No. of i of Total Invasive Carcinoma Grade Ductal, NOS Tubular Mucinous Lobular Mixed, tubular, and ductal Mixed, tubular, and lobular Total of all subtypes NOS = not otherwise specified. Values in parentheses are percentages. 8 7 The nonparametric Kendall Tau-B statistical analysis was used to study the relation between DCIS nuclear grade and the invasive carcinoma composite grade. The range of possible results for this test are to +. The closer the result to +, the stronger the relation between the two values being tested. RESULTS One hundred thirty-eight (%) of the 5 invasive carcinomas were ductal not otherwise specified (NOS) type; 7 (4%) were tubular; and the remainder were other subtypes (Table ). Fifty-one (4%) invasive carcinomas were grade, 58 (%) were grade, and 4 (7%) were grade. The mean size of the invasive carcinomas was. cm (range.-. cm). There were 4 cases (%) of pure nuclear grade DCIS (Table ). The remaining cases were almost evenly TABLE. DISTRIBUTION OF DCIS NUCLEAR GRADES DCIS Nuclear Grade Pure Mixed and 5-75% 6-5% -5% Pure Mixed and -5% 6-5% 5-75% No. of % of Total < < 4() 7() 5(4) 56 (4) 58() 4() 4(7) distributed between mixed nuclear grade and DCIS (8 cases, %), pure nuclear grade DCIS (5 cases, 4%), mixed nuclear grade and DCIS (7 cases, 5%), and pure nuclear grade DCIS ( cases, %). Three cases (%) were a mixture of nuclear grade and or nuclear grades,, and DCIS. A general association between the DCIS nuclear grade and invasive carcinoma grade was observed (Table ). Twelve of the 4 (86%) pure nuclear grade DCIS cases and 8 of the 8 (6%) mixed nuclear grade - cases were associated with grade invasive carcinomas. Of the 5 pure nuclear grade DCIS cases, 5 (4%) were associated with grade invasive carcinomas and (7%) were associated with grade invasive carcinomas. Eighteen (5%) of the 7 mixed nuclear grade and DCIS cases were associated with grade invasive carcinomas and 4 (6%) were associated with grade invasive carcinomas. Twenty of the (6%) of the pure nuclear grade DCIS cases were associated with grade invasive carcinomas. Nonparametric statistical analysis comparing the DCIS nuclear grade and the invasive carcinoma grade (Table ) produced a Kendall Tau-B value of.6. This confirms the observation of a moderately strong relation TABLE. DISTRIBUTION OF DCIS NUCLEAR GRADE AND INVASIVE CARCINOMA GRADE DCIS Nuclear Grade Invasive Carcinoma Grade No. of I i (%) Downloaded from by guest on November % 6-5% -5% Pure Mixed and and Mixed and DCIS = ductal carcinoma in situ. -5% 6-5% 5-75% Pure Mixed and Pure Mixed and Pure Mixed - and / Values are no. (%). DCIS = ductal carcinoma in situ. (86) 8(64) 5(4) 5() () (4) (6) (7) 8(5) (6) 7() 4(6) (6) 4() 8() 5() 7() () A.J.C.P.-September 6
4 GOLDSTEIN AND MURPHY 5 Intraductal Carcinoma TABLE 4. DISTRIBUTION OF DCIS ARCHITECTURAL PATTERNS Predominant Architectural Pattern DICS Nuclear Grade Cribriform Solid Micropapillary Centrally Necrotic Clinging No. of Pure Mixed and 4 4 Nuclear grades 8 No. of cases Pure Mixed and Nuclear grades No. of cases Pure grade DOS = ductal carcinoma in situ between the DCIS nuclear grade and the grade of the associated invasive carcinoma. All 4 cases of pure nuclear grade DCIS had a cribriform-predominant architectural pattern (Table 4). Of the 8 mixed nuclear grade and DCIS cases, cribriform was the predominant architectural pattern in (7%) of the grade and (75%) of the grade ducts. The predominant architectural pattern in almost all the other mixed nuclear grade and DCIS cases was solid. Eighteen of the 5 (5%) pure nuclear grade DCIS cases were predominantly cribriform, (4%) were solid, and 4(%) were predominantly centrally necrotic. Of the 7 mixed nuclear grade and DCIS cases, cribriform was the predominant architectural pattern in the grade ducts in 4 cases and of the grade ducts in 8 cases. Centrally necrotic pattern was the predominant architectural pattern in the nuclear grade ducts in of the mixed nuclear grade - cases. Centrally necrotic was also the predominant architectural pattern in 5 (46%) of the pure nuclear grade DCIS cases. Solid was the second most common architectural pattern in the pure nuclear grade DCIS cases. Second most common architectural patterns were evaluated for each DCIS nuclear grade. Similar to the predominant architectural pattern, there were no cases of pure grade DCIS or mixed nuclear grade and DCIS that had a centrally necrotic pattern. Other than this relation, there was marked heterogeneity of secondary architectural patterns in all the DCIS nuclear grade groups. Although some generalities could be observed, there was no statistically significant relation between the DCIS architectural pattern and the grade of the associated invasive carcinoma (Table 5). The majority of ducts composed of predominantly cribriform pattern DCIS were associated with grade invasive carcinomas. The predominantly solid pattern of DCIS was associated with all three grades of invasive carcinoma. All four cases of pure nuclear grade DCIS that formed predominantly centrally necrotic pattern were associated with grade invasive carcinomas. Thirteen of the pure nuclear grade, centrally necrotic pattern DCIS lesions were associated with grade invasive carcinomas, and the other two were associated with grade invasive carcinomas. DISCUSSION Intraductal breast carcinoma (DCIS) is a heterogeneous lesion, ' 4 " 7 in both its biologic behavior and morphology. What was initially recognized as a single entity has evolved over the last two decades into a rubric covering several entities. There are at least two subtypes of DCIS. The noncentrally necrotic, low nuclear grade subtype has low to minimal risk of recurrence after wide excision, whereas centrally necrotic, high nuclear grade (comedo) subtype has a high risk of recurrence despite TABLE 5. PREDOMINANT DCIS ARCHITECTURAL PATTERN AND INVASIVE CARCINOMA GRADE Predominant DCIS Architectural Pattern Cribriform Solid Micropapillary Clinging Centrally necrotic, pure grade Centrally necrotic, pure grade DCIS = ductal carcinoma in situ. 5 7 Invasive Carcinoma Grade / Downloaded from by guest on November 8 Vol. 6 «No.
5 6 ANATOMIC PATHOLOGY Article radiation therapy and complete conservative excision. 44 " 8 Quantitative and qualitative components of DCIS contribute to its differences in recurrence risk. Authors have attempted to classify each component to predict the risk of residual tumor or recurrence after local excision (of the DCIS and/or associated invasive carcinoma) or to establish the risk of a coexistent invasive carcinoma. Quantitative components have included findings of Lagios and colleagues' that a DCIS lesion greater than.5 cm has a significant association with invasive carcinoma and multicentricity or that "extensive intraductal carcinoma" associated with an invasive carcinoma has a significant risk of having residual DCIS within the breast after local excision. " 5 Qualitative histologic parameters for DCIS have included nuclear size and grade, architecture, presence and pattern of necrosis, c-erb- protein, p5 protein, estrogen and progesterone receptor expression, and DNA analysis. 4 " 6 ' I4-6 " 4 Nuclear grade of the DCIS has been one of the most extensively studied qualitative histologic parameters.' " 7i467 ' 6 ' '- 5 " 8 However, the amount of DCIS nuclear heterogeneity that can exist within a lesion has received little attention. Our results show that, unlike DCIS architecture, which can be extremely heterogeneous, 5,6 nuclear heterogeneity within a patient's DCIS (associated with invasive carcinoma) is minimal. The clear majority of women in our study had either DCIS with a single nuclear grade or DCIS composed of two adjacent nuclear grades. Only of 5 cases, % of our cases, had a mixture of grade and grade DCIS. In contrast, we observed a continuous spectrum of DCIS nuclear grades from different women. Pure nuclear grade DCIS comprised the smallest group of lesions, % of the 5 cases. The remainder of the lesions were almost evenly distributed between nuclear grade and, pure nuclear grade, mixed nuclear grade and, and pure nuclear grade DCIS. Additionally, there was an almost even distribution of cases between the percentage of DCIS nuclear grades within the mixed-grade DCIS cases. These results require examination in light of how previous authors have approached DCIS nuclear grading. The classifications of DCIS nuclear grades have varied depending on the goal of the study. In descriptive studies of DCIS, such as the one by Lennington and colleagues, 6 a four-tiered grading scheme was used, and in cases with multiple nuclear grades, the nuclear grade of each pattern was averaged, producing a single final nuclear grade for each case. Moriya and associates' compared pure DCIS and DCIS associated with invasive carcinomas and classified the DCIS nuclear grade using a three-tiered system based on the highest nuclear grade. Patchefsky and coworkers 5 examined various features of DCIS in biopsies and related them to the findings seen in the mastectomy specimens. They also used a three-tiered nuclear grading system and classified the DCIS based on the highest nuclear grade. The greatest differences in how investigators have approached DCIS nuclear grading are found in studies that examined features of DCIS to predict failure with breastconserving therapy. Lagios and colleagues 4 classified DCIS nuclei into three grades and combined nuclear grading with architectural patterns to produce four DCIS subtypes, keeping each nuclear tier distinct. The NSABP Protocol B-7 had a similar goal. The authors initially classified DCIS nuclei using a three-tiered system and then, for statistical analysis, grouped nuclear grades and as "good" and as "poor'.' 7 DCIS lesions containing both "good" and "bad" nuclei were grouped as "poor" There are several extant DCIS classification systems, based primarily on the architectural pattern." A drawback to these classification systems is DCIS architectural heterogeneity. 5,6 Recently, Holland and colleagues 4 published a DCIS classification system that uses nuclear grade as the primary classification criterion and DCIS architecture as a subclassification criterion. This classification system has support from prior studies,' 4 although, as pointed out by Fisher and colleagues, this classification may be more of a nosologic issue than a truly new classification. Another criticism of the Holland and colleagues' classification system noted by Lagios, is that it discounts nuclear size as an intricate component of the DCIS classification. Our results support the use of the Holland and colleagues' DCIS classification system, because we found that there is only a narrow spectrum of DCIS nuclear grades within a given patient's lesion, and, aside from the infrequent nuclear grade DCIS, there was an almost even distribution of DCIS nuclear grades within our study population. This provides evidence for consistency of Holland's primary grading criterion. Had there been a clustering of DCIS nuclear grades within the study population, or marked nuclear grade variation within a patients' DCIS, it would have cast doubts on the merits of this classification system. Ideally, there should only be one method of classifying DCIS. The ideal classification system would provide all the prognostically useful information that our clinical colleagues require. Also, it should be straightforward and simple enough that it can be applied consistently and uniformly by pathologists. If DCIS prognostic features were a static issue, the creation of an ideal DCIS classification system would be a relatively simple task. How- Downloaded from by guest on November 8 A.J.C.P.^ :r 6
6 GOLDSTEIN AND MURPHY 7 Intraductal Carcinoma ever, qualitative and qualitative DCIS prognostic parameters are in a state of flux. The significance of some parameters and the optimal methods of their evaluation are subjects of active debate. 7 " It must also be recognized that DCIS can occur as a pure lesion or be found in association with invasive carcinoma. It is unknown whether similar-appearing DCIS lesions act differently or have the same biologic or predictive significance when they are associated with invasive carcinomas versus when they occur in pure form. An ideal DCIS classification system must be adaptable to the changing qualitative and quantitative prognostic features as they evolve. Our study also examined the relationship between DCIS nuclear grade and grade of invasive carcinoma. We found, in general, a trend between the DCIS nuclear grade and the invasive carcinoma grade. Pure nuclear grade DCIS was associated only with grade invasive carcinomas. Mixed nuclear grade and DCIS was associated with grade or invasive carcinomas, and nuclear grades and/ or DCIS were associated predominantly with grade and invasive carcinomas. These findings corroborate those of other authors. - Lampejo and colleagues performed a similar study that included stage and invasive carcinomas. Only 8% of the tumors were pathologic T-stage (< cm). They classified DCIS using the Holland and colleagues' classification system. 4 They found a highly significant association between the grade of the infiltrating carcinoma and the DCIS grade. Grade DCIS was associated with welldifferentiated invasive carcinomas, grade DCIS was usually associated with moderately differentiated invasive carcinomas, and grade DCIS was associated with poorly differentiated invasive carcinomas. These results support the idea that well-differentiated DCIS gives rise to well-differentiated invasive carcinoma. Our results, which derived from the study of pathologic stage-tl invasive carcinomas (mean diameter of. cm), and those of Lampejo and colleagues, both suggest that the nuclear grade of DCIS associated with invasive carcinoma does not transform over the time that the invasive component is growing and enlarging. Seven percent of DCIS lesions in their series were grade. This is close to our figure of % of cases with pure nuclear grade DCIS. That both studies had almost the same percentage of grade DCIS cases, although almost of of their cases exceeded cm (mean.8 cm, range -8.5 cm), supports the concept that the nuclear grade of DCIS remains constant throughout much of the evolution of the DCIS lesion, even after the DCIS has eventuated into invasive carcinoma. We corroborate the findings of others that DCIS architectural patterns can be heterogeneous. ' ' 4 In general, low grade nuclear DCIS forms predominantly cribriform patterns, whereas DCIS with high-grade nuclei forms centrally necrotic or solid patterns. Centrally necrotic architectural pattern was not seen in cases with DCIS nuclear grade, All architectural patterns were seen in the cases with higher DCIS nuclear grades. Four cases of pure nuclear grade, predominantly centrally necrotic DCIS, were associated with grade invasive carcinomas, whereas of 5 cases of pure nuclear grade, predominantly centrally necrotic DCIS were associated with grade invasive carcinomas. Although this number of cases is too small to derive any significant conclusions, it supports the hypothesis that nuclear grade, rather than DCIS architecture, is the most important predictor of the grade of an associated invasive carcinoma. In summary, we found that there is a great variation of nuclear grade within a large group of women with DCIS; however, there is minimal DCIS nuclear grade variation within each individual patient's lesion. Regardless of the nuclear uniformity within a DCIS lesion, there could be marked architectural variation of the DCIS. In general, the grade of the DCIS is associated with the grade of the invasive carcinoma. Acknowledgments. The authors thank Drs. J. Watts. J. Neill, and R. Goldstein for their editorial comments. REFERENCES. Moriya T, Silverberg SG. Intraductal carcinoma (ductal carcinoma in situ) of the breast: A comparison of pure noninvasive tumors with those including different proportions of infiltrating carcinoma. Cancer 4;74: Lampejo OT, Barnes DM, Smith P, Millis RR. Evaluation of infiltrating ductal carcinomas with a DCIS component: Correlation of the histologic type of the in situ component with grade of the infiltrating component. Sent Diag Pathol 4; :5-.. Enjoji M. Toyoshima S. Ductal carcinoma of the breast: An analysis of proportions of intraductal and invasive carcinoma. Path ResPract ;87: Lagios MD, Margilin FR, Westdahl PR, Rose MR. Mammographically detected duct carcinoma in situ: Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade in local recurrence. Cancer 8;6: Patchefsky AS, Schwartz GF, Finkelstein SD, et al. Heterogeneity of intraductal carcinoma of the breast. Cancer 8:6: Lennington WJ. Jensen RA, Dalton LW, Page DL. Ductal carcinoma in situ of the breast: Heterogeneity of individual lesions. Cancer 4:7: Fisher ER, Costantino J, Fisher B, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-7: Intraductal carcinoma (ductal carcinoma in situ). Cancer 5;75:-. 8. Page DL. Lagios MD. Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP) B-7 trial: Unanswered questions remaining unanswered considering current concepts of ductal carcinoma in situ. Cancer 5;75:-.. Fisher ER, Costantino J, Fisher B, Palekar AS, Mamounas E. Response-Blunting the counterpoint. Cancer 5;75:-7. Downloaded from by guest on November 8 Vol. 6-No.
7 8 ANATOMIC PATHOLOGY Original Article. Lagios MD. Ductal carcinoma in situ: Controversies in diagnosis, biology, and treatment. The Breast Journal 5; : Page DL, Anderson TJ. Diagnostic Histopathology of the Breast. Edinburgh: Churchill Livingstone, 87.. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology ;:4-4.. Fechner RE. One century of mammary carcinoma in situ: What have we learned? Am J Clin Pathol ; : Solin U, Yeh IT, Kurtz J, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation: Correlation of pathologic parameters with outcome of treatment. Cancer ; 7: Poller DN, Silverstein MJ, Galea M, et al. Ductal carcinoma in situ of the breast: A proposal for a new simplified histological classification association between cellular proliferation and c- erbb- protein expression. Mod Pathol 4;7: Ottesen GL, Graversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Ductal carcinoma in situ of the female breast: Short-term results of a prospective nationwide study. Am J Surg Pathol ;6: Bellamy COC, McDonald C, Salter DM, Chetty U, Anderson TJ. Noninvasive ductal carcinoma of the breast: The relevance of histologic categorization. Hum Pathol ;4: Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 5-5 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated by biopsy only. Cancer 5;76:7-.. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ: Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 8; 5: -4.. Boyages J, Recht A, Connolly J, et al. Early breast cancer: Predictors of breast recurrence for patients treated with conservative surgery and radiation therapy. Radiother Oncol ; :-4.. Jacquemier J, Kurtz J, Amalric R, et al. An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy. Br J Cancer ;6: Fourquet A, Campana F, Zafrani B, et al. Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 5-year follow-up. Int J Radial Oncol Biol Phys 8;7: Borger J, Kemperman H, Hart A, et al. Risk factors in breast-conservation therapy. J Clin Oncol 4; : Schnitt SJ. Connolly J, Khettry U, et al. Pathologic findings on reexcision of the primary site in breast cancer patients considered for treatment by primary radiation therapy. Cancer 87; 5: Holland R, Connolly J, Gelman R, et al. The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol ; 8: Leal CB, Schmitt FC, Bento MJ, Maia NC, Lopes CS. Ductal carcinoma in situ of the breast: Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p5, and c-erb-b- protein. Cancer 5;75:-. 7. Wilber DC, Barrows GH. Estrogen and progesterone receptor and c-erbb- oncoprotein analysis in pure in situ breast carcinoma: An immunohistochemical study. Mod Pathol ;6: Bur ME, Zimarowski MJ, Schnitt SJ, Baker S, Lew R. Estrogen receptor immunohistochemistry in carcinoma in situ of the breast. Cancer ; 6: Lodato RF, Maguire HC, Greene MI, Weiner DB, LiVolsi VA. Immunohistochemical evaluation ofc-erbb- oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Mod Pathol ;: Schimmelpenning H, Eriksson ET, Pallis L, et al. Immunohistochemical c-erbb- proto-oncogene expression and nuclear DNA content in human mammary carcinoma in situ. Am J Clin Pathol ;7(suppl ):S48-S5.. Killeen JL, Namiki H. DNA analysis of ductal carcinoma in situ of the breast. Cancer ;68: Ramachandra S, Machin L, Ashley S, Monaghan P, Gusterson BA. Immunohistochemical distribution ofc-erbb- in in situ breast carcinoma: A detailed morphological analysis. J Pathol ;6:7-4.. Zifrani B, Leroyer A, Fourquet A, et al. Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 7 cases: Correlation with estrogen and progesterone receptors, p5, and c-erbb- proteins, and proliferative activity. Sem Diag Pathol 4; : De Potter CR, Schelfhout A, Verbeeck P, et al. Neu overexpression correlates with extent of disease in large cell ductal carcinoma in situ of the breast. Hum Pathol 5;6: Fisher ER, Siderits R. Value of cytometric analysis for distinction of intraductal carcinoma of the breast. Breast Cancer Res Treat ;: Eusebi V, Feudale E, Foschini MP, et al. Long-term follow-up of in situ carcinoma of the breast. Sem Diag Pathol 4; : Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma in situ. Lancet 5:45: Sneige N, McNeese MD, Atkinson EN, et al. Ductal carcinoma in situ treated with lumpectomy and irradiation: Histopathological analysis of 4 specimens with emphasis on risk factors and long-term results. Hum Pathol 5;6: Rosen PP, Oberman HA. Intraepithelial (preinvasive or in situ) carcinoma. In: Atlas of Tumor Pathology, ed. Washington, DC: Armed Forces Institute of Pathology Press,, pp Holland R, Peterse J, Millis RR, et al. Ductal carcinoma in situ: A proposal for a new classification. Sem Diag Pathol 4; : Downloaded from by guest on November 8 A.J.C.P. September 6
Management of Ductal Carcinoma In Situ
Management of Ductal Carcinoma In Situ Stella Hetelekidis, MD Stuart J. Schnitt, MD Monica Morrow, MD Jay R. Harris, MD Introduction Ductal carcinoma in situ (DCIS), also known as intraductal carcinoma,
More informationRecurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction
Recurrence following Treatment of Ductal Carcinoma in Situ with Skin-Sparing Mastectomy and Immediate Breast Reconstruction Aldona J. Spiegel, M.D., and Charles E. Butler, M.D. Houston, Texas Skin-sparing
More informationGrade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast
British Journal of Cancer (2004) 90, 1538 1542 All rights reserved 0007 0920/04 $25.00 www.bjcancer.com Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in
More informationDuctal Carcinoma In Situ of the Breast
2123 Ductal Carcinoma In Situ of the Breast Histologic Categorization and Its Relationship to Ploidy and Immunohistochemical Expression of Hormone Receptors, p53, and c-erbb-2 Protein ConceigZo B. Leal,
More informationTHE INFLUENCE OF MARGIN WIDTH ON LOCAL CONTROL OF DUCTAL CARCINOMA IN SITU OF THE BREAST
THE INFLUENCE OF MARGIN WIDTH ON LOCAL CONTROL OF DUCTAL CARCINOMA IN SITU OF THE BREAST MELVIN J. SILVERSTEIN, M.D., MICHAEL D. LAGIOS, M.D., SUSAN GROSHEN, H.D., JAMES R. WAISMAN, M.D., BERNARD S. LEWINSKY,
More informationInt. J. Curr. Res. Med. Sci. (2018). 4(7): 1-7. International Journal of Current Research in Medical Sciences
International Journal of Current Research in Medical Sciences ISSN: 2454-5716 P-ISJN: A4372-3064, E -ISJN: A4372-3061 www.ijcrims.com Original Research Article Volume 4, Issue 7-2018 DOI: http://dx.doi.org/10.22192/ijcrms.2018.04.07.001
More informationOriginal Article. Spontaneous Healing of Breast Cancer
Breast Cancer Vol. 12 No. 2 April 2005 Original Article Rie Horii 1, 3, Futoshi Akiyama 1, Fujio Kasumi 2, Morio Koike 3, and Goi Sakamoto 1 1 Department of Breast Pathology, the Cancer Institute of the
More informationTumour markers in breast carcinoma correlate with grade rather than with invasiveness
doi: 10.1054/ bjoc.2001.1995, available online at http://www.idealibrary.com on http://www.bjcancer.com Tumour markers in breast carcinoma correlate with grade rather than with invasiveness F Wärnberg
More informationSurgical Pathology Issues of Practical Importance
Surgical Pathology Issues of Practical Importance Anne Moore, MD Medical Oncology Syed Hoda, MD Surgical Pathology The pathologist is central to the team approach needed to manage the patient with breast
More informationIn Situ Breast Carcinoma. James L. Connolly, M.D Beth Israel Deaconess Medical Center Professor of Pathology Harvard Medical School Boston, MA
In Situ Breast Carcinoma James L. Connolly, M.D Beth Israel Deaconess Medical Center Professor of Pathology Harvard Medical School Boston, MA Content In Situ Ductal Carcinoma In Situ Lobular Carcinoma
More informationEpithelial Columnar Breast Lesions: Histopathology and Molecular Markers
29th Annual International Conference Advances in the Application of Monoclonal Antibodies in Clinical Oncology and Symposium on Cancer Stem Cells 25 th -27t h June, 2012, Mykonos, Greece Epithelial Columnar
More informationCLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES
Papillomas. Papillomas are composed of multiple branching fibrovascular cores, each having a connective tissue axis lined by luminal and myoepithelial cells ( Fig. 23-11 ). Growth occurs within a dilated
More informationInterpretation of Breast Pathology in the Era of Minimally Invasive Procedures
Shahla Masood, M.D. Professor and Chair Department of Pathology and Laboratory Medicine University of Florida College of Medicine Jacksonville Medical Director, UF Health Breast Center Chief of Pathology
More informationUltrastructure of the Periductal Area of Comedo Carcinoma in situ of the Breast
284 Annals of Clinical & Laboratory Science, vol. 31, no. 3, 2001 Ultrastructure of the Periductal Area of Comedo Carcinoma in situ of the Breast Ping Tang, Saul Teichberg, Beth Roberts, and Steven I.
More informationDuctal Carcinoma In Situ of the Breast: Controversial Issues
Ductal Carcinoma In Situ of the Breast: Controversial Issues MELVIN J. SILVERSTEIN The Breast Center*, Van Nuys, California, USA Key Words. DCIS Ductal carcinoma in situ Noninvasive breast cancer Intraductal
More informationBasement membrane in lobule.
Bahram Memar, MD Basement membrane in lobule. Normal lobule-luteal phase Normal lobule-follicular phase Lactating breast Greater than 95% are adenocarcinomas in situ carcinomas and invasive carcinomas.
More informationInternational Society of Gynecological Pathologists Symposium 2007
International Society of Gynecological Pathologists Symposium 2007 Anais Malpica, M.D. Department of Pathology The University of Texas M.D. Anderson Cancer Center Grading of Ovarian Cancer Histologic grade
More informationDuctal Carcinoma-in-Situ: New Concepts and Controversies
Ductal Carcinoma-in-Situ: New Concepts and Controversies James J. Stark, MD, FACP Medical Director, Cancer Program and Palliative Care Maryview Medical Center Professor of Medicine, EVMS Case Presentation
More informationBalancing Evidence and Clinical Practice in the Treatment of Localized Breast Cancer May 5, 2006
Balancing Evidence and Clinical Practice in the Treatment of Localized Breast Cancer May 5, 2006 Deborah Hamolsky MS, RN : DCIS Carol Franc Buck Breast Care Center UCSF Comprehensive Cancer Center Jane
More informationHistological Type. Morphological and Molecular Typing of breast Cancer. Nottingham Tenovus Primary Breast Cancer Study. Survival (%) Ian Ellis
Morphological and Molecular Typing of breast Cancer Ian Ellis Molecular Medical Sciences, University of Nottingham Department of Histopathology, Nottingham University Hospitals NHS Trust Histological Type
More informationNeuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters
& 2004 USCAP, Inc All rights reserved 0893-3952/04 $25.00 www.modernpathology.org Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical
More informationProliferative Breast Disease: implications of core biopsy diagnosis. Proliferative Breast Disease
Proliferative Breast Disease: implications of core biopsy diagnosis Jean F. Simpson, M.D. Breast Pathology Consultants, Inc. Nashville, TN Proliferative Breast Disease Must be interpreted in clinical and
More informationA712(19)- Test slide, Breast cancer tissues with corresponding normal tissues
A712(19)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only Specifications: No. of cases: 12 Tissue type: Breast cancer tissues with corresponding
More informationPapillary Lesions of the Breast A Practical Approach to Diagnosis. (Arch Pathol Lab Med. 2016;140: ; doi: /arpa.
Papillary Lesions of the Breast A Practical Approach to Diagnosis (Arch Pathol Lab Med. 2016;140:1052 1059; doi: 10.5858/arpa.2016-0219-RA) Papillary lesions of the breast Span the spectrum of benign,
More informationLOBULAR CARCINOMA IN SITU: WHAT DOES IT MEAN? THE SURGEON'S PERSPECTIVE
: WHAT DOES IT MEAN? THE SURGEON'S PERSPECTIVE Benjamin O. Anderson, M.D. Director, Breast Health Clinic Professor of Surgery and Global Health, University of Washington Joint Member, Fred Hutchinson Cancer
More informationRadiation and DCIS. The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging
Radiation and DCIS The 16 th Annual Conference on A Multidisciplinary Approach to Comprehensive Breast Care and Imaging Einsley-Marie Janowski, MD, PhD Assistant Professor Department of Radiation Oncology
More informationA712(18)- Test slide, Breast cancer tissues with corresponding normal tissues
A712(18)- Test slide, Breast cancer tissues with corresponding normal tissues (formalin fixed) For research use only Specifications: No. of cases: 12 Tissue type: Breast cancer tissues with corresponding
More informationACRIN 6666 Therapeutic Surgery Form
S1 ACRIN 6666 Therapeutic Surgery Form 6666 Instructions: Complete a separate S1 form for each separate area of each breast excised with the intent to treat a cancer (e.g. each lumpectomy or mastectomy).
More informationColumnar Cell Lesions
Columnar Cell Lesions Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Question? Columnar cell lesions are: a) Annoying lesions
More informationCarcinoma mammario: le istologie non frequenti. Valentina Guarneri Università di Padova IOV-IRCCS
Carcinoma mammario: le istologie non frequenti Valentina Guarneri Università di Padova IOV-IRCCS Histological diversity of breast adenocarcinomas Different histological types are defined according to specific
More informationCytyc Corporation - Case Presentation Archive - March 2002
FirstCyte Ductal Lavage History: 68 Year Old Female Gail Index: Unknown Clinical History: Negative Mammogram in 1995 6 yrs. later presents with bloody nipple discharge Subsequent suspicious mammogram Suspicious
More informationDisclosures. Premalignant Lesions of the Breast: What Clinicians Want and Why. NY Times: Prone to Error: Earliest Steps to Find Cancer.
Disclosures Premalignant Lesions of the Breast: What Clinicians Want and Why I have nothing to disclose Rick Baehner, MD Assistant Professor, UCSF Pathology NY Times: Prone to Error: Earliest Steps to
More informationProtocol for the Examination of Biopsy Specimens From Patients With Invasive Carcinoma of the Breast
Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast Version: BreastInvasive 1.0.0.0 Protocol Posting Date: February 2019 Accreditation Requirements The use of
More informationEvaluation of Breast Specimens Removed by Needle Localization Technique
Evaluation of Breast Specimens Removed by Needle Localization Technique Specimen Handling: The breast specimen when received should be measured and grossly inspected for any orientation designated by the
More informationPapillary Lesions of the Breast: WHO Update
Papillary Lesions of the Breast: WHO Update Stuart J. Schnitt, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA, USA Papillary Lesions of the Breast
More informationCASE REPORT Malignant transformation of breast ductal adenoma: a diagnostic pitfall
Malaysian J Pathol 2015; 37(3) : 281 285 CASE REPORT Malignant transformation of breast ductal adenoma: a diagnostic pitfall Hiroko HAYASHI, Hiroshi OHTANI,* Junzo YAMAGUCHI,** and Isao SHIMOKAWA Department
More informationProliferative Epithelial lesions of the Breast. Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London
Proliferative Epithelial lesions of the Breast Sami Shousha, MD, FRCPath Charing Cross Hospital & Imperial College, London Amman, November2013 Proliferative Epithelial Lesions of the Breast Usual type
More informationDuctal Proliferations of the Breast: The Good, the Bad, and the Ugly
Ductal Proliferations of the Breast: The Good, the Bad, and the Ugly Melinda F. Lerwill, MD CRITERIA FOR DISTINGUISHING LOW-GRADE DUCTAL CARCINOMA IN SITU FROM USUAL DUCTAL HYPERPLASIA CYTOLOGY Low-grade
More informationBreast Pathology. Breast Development
Breast Pathology Lecturer: Hanina Hibshoosh, M.D. Reading: Kumar, Cotran, Robbins, Basic Pathology, 6th Edition, pages 623-635 Breast Development 5th week - thickening of the epidermis - milk line 5th
More informationPalpable Breast Lesions Cytomorphological Analysis and Scoring System with Histopatholgical Correlation
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 15, Issue 10 Ver. III (October. 2016), PP 25-29 www.iosrjournals.org Palpable Breast Lesions Cytomorphological
More informationDOCTORAL THESIS SUMMARY
UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA FACULTY OF MEDICINE DOCTORAL THESIS SUMMARY CLINICO-IMAGING STUDY OF INVASIVE DUCTAL BREAST CARCINOMAS CORRELATED TO HORMONAL RECEPTORS AND HER2/NEU ONCOPROTEIN
More informationFlat Epithelial Atypia
Flat Epithelial Atypia Richard Owings, M.D. University of Arkansas for Medical Sciences Department of Pathology Flat epithelial atypia can be a difficult lesion May be a subtle diagnosis Lots of changes
More informationLobular Carcinoma In Situ Variants in Breast Cores
Lobular Carcinoma In Situ Variants in Breast Cores Potential for Misdiagnosis, Upgrade Rates at Surgical Excision, and Practical Implications Megan E. Sullivan, MD; Seema A. Khan, MD; Yurdanur Sullu, MD;
More informationDiseases of the breast (2 of 2) Breast cancer
Diseases of the breast (2 of 2) Breast cancer Epidemiology & etiology The most common type of cancer & the 2 nd most common cause of cancer death in women 1 of 8 women in USA Affects 7% of women Peak at
More informationPapillary Lesions of the Breast
Papillary Lesions of the Breast Laura C. Collins, M.D. Associate Professor of Pathology Associate Director, Division of Anatomic Pathology Beth Israel Deaconess Medical Center and Harvard Medical School
More informationImmunohistochemical studies (ER & Ki-67) in Proliferative breast lesions adjacent to malignancy
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 13, Issue 3 Ver. IV. (Mar. 2014), PP 84-89 Immunohistochemical studies (ER & Ki-67) in Proliferative
More informationPathologic Features of Breast Cancers in Women With Previous Benign Breast Disease
Anatomic Pathology / BREAST CANCERS AFTER BENIGN BIOPSY DIAGNOSES Pathologic Features of Breast Cancers in Women With Previous Benign Breast Disease Timothy W. Jacobs, MD, 1 Celia Byrne, PhD, 2 Graham
More informationCellular Dyscohesion in Fine-Needle Aspiration of Breast Carcinoma Prognostic Indicator for Axillary Lymph Node Metastases?
natomic Pathology / PROGNOSTIC INDICTOR FOR XILLRY LYMPH NODE METSTSES Cellular Dyscohesion in Fine-Needle spiration of reast Carcinoma Prognostic Indicator for xillary Lymph Node Metastases? nne. Schiller,
More informationContents 1 The Windows of Susceptibility to Breast Cancer 2 The So Called Pre-Neoplastic Lesions and Carcinoma In Situ
Contents 1 The Windows of Susceptibility to Breast Cancer... 1 1.1 Introduction... 1 1.2 Risk Factor and Etiological Agents... 2 1.3 The Concept of the Windows of Susceptibility to Carcinogenesis... 5
More informationTenascin Patterns of Expression in Duct Carcinoma In Situ of the Breast
266 Annals o f Clinical & Laboratory Science, vol. 30, no. 3, 2000 Tenascin Patterns of Expression in Duct Carcinoma In Situ of the Breast Basem F. Iskaros, Cristina P. Sison, and Steven I. Hajdu Department
More informationDuctal carcinoma in situ
Breast series CLINICAL PRACTICE Ductal carcinoma in situ Management update Kirsty Stuart, BSc (Med), MBBS, FRANZCR, is a radiation oncologist, NSW Breast Cancer Institute, Westmead Hospital, New South
More informationBreast pathology. 2nd Department of Pathology Semmelweis University
Breast pathology 2nd Department of Pathology Semmelweis University Breast pathology - Summary - Benign lesions - Acute mastitis - Plasma cell mastitis / duct ectasia - Fat necrosis - Fibrocystic change/
More informationAccuracy of Specimen Radiography in Assessing Complete Local Excision with Breast-Conservation Surgery
RESEARCH ARTICLE Editorial Process: Submission:09/22/2017 Acceptance:01/21/2018 Accuracy of Specimen Radiography in Assessing Complete Local Excision with Breast-Conservation Surgery Saira Naz, Imrana
More informationBreast Carcinoma in Pakistani Females: A. Morphological Study of 572 Breast Specimens
Breast Carcinoma in Pakistani Females: A. Morphological Study of 572 Breast Specimens M. Shahid Siddiqui,Naila Kayani,Sara Sulaiman,Akbar S. Hussainy,Sajid H. Shah,Suhail Muzaffar ( Faculty of Health Sciences,
More informationACCME/Disclosures. Cribriform Lesions of the Prostate. Case
Cribriform Lesions of the Prostate Ming Zhou, MD, PhD Departments of Pathology and Urology New York University Langone Medical Center New York, NY Ming.Zhou@NYUMC.ORG ACCME/Disclosures The USCAP requires
More informationIntraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance
& 2006 USCAP, Inc All rights reserved 0893-3952/06 $30.00 www.modernpathology.org Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance Charles C Guo 1 and
More information1 NORMAL HISTOLOGY AND METAPLASIAS
1 NORMAL HISTOLOGY AND METAPLASIAS, MD Anatomy and Histology 1 Metaplasias 2 ANATOMY AND HISTOLOGY The female breast is composed of a branching duct system, which begins at the nipple with the major lactiferous
More informationKey Words: Cytology, Grading, Breast Carcinoma
BREAST CARCINOMA ASPIRATES: A STUDY ON CYTOLOGICAL GRADING *Subhashish Das, Kalyani and Harendra Kumar Department of Pathology; Sri Devaraj Urs Medical College, Tamaka, Kolar *Author for Correspondence
More informationPromise of a beautiful day
Promise of a beautiful day Ductal carcinoma in Situ Lobular Carcinoma in Situ Natural History Manosmed Tartous Oct 2009 Gérard ABADJIAN MD Pathology Department Hôtel-Dieu de France. Associate Professor
More informationIn situ lobular neoplasia of the breast with marked myoepithelial proliferation
In situ lobular neoplasia of the breast with marked myoepithelial proliferation Sami Shousha To cite this version: Sami Shousha. In situ lobular neoplasia of the breast with marked myoepithelial proliferation.
More informationOriginal Articles. Clinical Implications of Margin Involvement by Pleomorphic Lobular Carcinoma In Situ
Original Articles Clinical Implications of Margin Involvement by Pleomorphic Lobular Carcinoma In Situ Erinn Downs-Kelly, DO; Diana Bell, MD; George H. Perkins, MD; Nour Sneige, MD; Lavinia P. Middleton,
More informationLesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node
Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node Oil Cyst Mass, Intermediate Concern Microlobulated Margins Obscured Margins Mass, Favoring Malignant Indistinct
More informationc-erbb-2 overexpression and histologlical type of in situ and invasive breast carcinoma
16 J Clin Pathol 1992;45:16-20 Department of Histopathology, Belfast City Hospital, Lisburn Road, Belfast BT9 7AD J E Somerville L A Clarke J D Biggart Correspondence to: Dr J Somerville Accepted for publication
More informationDisclosures 5/27/2012. Outline of Talk. Outline of Talk. When Is LCIS Clinically Significant? Classic LCIS. Classic LCIS
When Is LCIS Clinically Significant? Disclosures I have nothing to disclose Yunn-Yi Chen, MD, PhD Professor Outline of Talk Outline of Talk Classic LCIS Classic LCIS Definition of lobular differentiation
More informationCase Scenario 1. 2/15/2011 The patient received IMRT 45 Gy at 1.8 Gy per fraction for 25 fractions.
Case Scenario 1 1/3/11 A 57 year old white female presents for her annual mammogram and is found to have a suspicious area of calcification, spread out over at least 4 centimeters. She is scheduled to
More informationROBINSON CYTOLOGICAL GRADING OF BREAST CARCINOMA ON FINE NEEDLE ASPIRATION CYTOLOGY- AN OVERVIEW
Page564 Research Article Biological Sciences ROBINSON CYTOLOGICAL GRADING OF BREAST CARCINOMA ON FINE NEEDLE ASPIRATION CYTOLOGY- AN OVERVIEW Charusheela Rajesh Gore, Chandanwale Shirish S, Ruchika Aggarwal,
More informationDuctal Carcinoma in Situ. Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA
Ductal Carcinoma in Situ Laura C. Collins, M.D. Department of Pathology Beth Israel Deaconess Medical Center and Harvard Medical School Boston, MA Definition of DCIS WHO 2012 A neoplastic proliferation
More information6/3/2010. Outline of Talk. Lobular Breast Cancer: Definition of lobular differentiation. Common Problems in Diagnosing LCIS in Core Biopsies
Outline of Talk Lobular Breast Cancer: Common Problems in Diagnosing LCIS in Core Biopsies Definition of lobular differentiation Variants of LCIS that: carry risk for unsampled invasive cancer mimic DCIS
More informationMammographic imaging of nonpalpable breast lesions. Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand
Mammographic imaging of nonpalpable breast lesions Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand Introduction Contents Mammographic signs of nonpalpable breast cancer
More informationBenign Breast Disease and Breast Cancer Risk
Benign Breast Disease and Breast Cancer Risk Jean F. Simpson, M.D. Vanderbilt University Nashville, Tennessee December 1, 2011 Nashville Nashville Lebanon 1 Cedars of Lebanon State Park The American University
More informationTriple Negative Breast Cancer
Triple Negative Breast Cancer Prof. Dr. Pornchai O-charoenrat Division of Head-Neck & Breast Surgery Department of Surgery Faculty of Medicine Siriraj Hospital Breast Cancer Classification Traditional
More informationDecember 2002 Monthly Memo
FLORIDA CANCER DATA SYSTEM December 2002 Monthly Memo CODING COMPLEX MORPHOLOGIC DIAGNOSES CODING COMPLEX BREAST HISTOLOGIES Apply these guidelines in priority order. Use the first guideline that applies
More informationConcordance with Breast Cancer Pathology Reporting Practice Guidelines
Concordance with Breast Cancer Pathology Reporting Practice Guidelines Neal W Wilkinson, MD, FACS, Azin Shahryarinejad, MD, Janet S Winston, MD, Nancy Watroba, MPA, Stephen B Edge, MD, FACS BACKGROUND:
More informationFlat Epithelial Atypia: A Review of Current Concepts
90 The Open Breast Cancer Journal, 2010, 2, 90-94 Flat Epithelial Atypia: A Review of Current Concepts Amy L. Adams * Open Access Department of Pathology and Laboratory Medicine, Emory University School
More information04/10/2018 HIGH RISK BREAST LESIONS. Pathology Perspectives of High Risk Breast Lesions ELEVATED RISK OF BREAST CANCER HISTORICAL PERSPECTIVES
Pathology Perspectives of High Risk Breast Lesions Savitri Krishnamurthy MD Professor of Pathology Deputy Division Head Director of Clinical Trials, Research and Development The University of Texas MD
More informationAtypical Ductal Hyperplasia and Papillomas: A Comparison of Ultrasound Guided Breast Biopsy and Stereotactic Guided Breast Biopsy
Atypical Ductal Hyperplasia and Papillomas: A Comparison of Ultrasound Guided Breast Biopsy and Stereotactic Guided Breast Biopsy Breast Cancer is the most common cancer diagnosed in women in the United
More informationPathology of Lobular & Ductal Preneoplasia. Syed A Hoda, MD Weill-Cornell, New York, NY
Pathology of Lobular & Ductal Preneoplasia Syed A Hoda, MD Weill-Cornell, New York, NY Proliferative Epithelial Changes in Breast A wide range of proliferative epithelial changes occur in the breast There
More informationPapillary Lesions of the breast
Papillary Lesions of the breast Emad Rakha Professor of Breast Pathology The University of Nottingham Papillary lesions of the breast are a heterogeneous group of disease, which are characterised by neoplastic
More informationMichael J. Wagoner, MD, 1 Christine Laronga, MD, 2 and Geza Acs, MD, PhD 1-3. Abstract
Anatomic Pathology / ADH in Breast Core Needle Biopsy Specimens Extent and Histologic Pattern of Atypical Ductal Hyperplasia Present on Core Needle Biopsy Specimens of the Breast Can Predict Ductal Carcinoma
More informationGOALS AND OBJECTIVES BREAST PATHOLOGY
GOALS AND OBJECTIVES BREAST PATHOLOGY LEVEL: PGY2, PGY3, PGY5 A number of these rotations are introductory in nature, as they are major subspecialties, and are followed by two more blocks in PGY-3, during
More informationRare types of breast carcinoma
Open Med. 2015; 10: 92-96 Research Article Open Access Daiva Gudaviciene*, Laura Steponaviciene, Raimundas Meskauskas, Giedre Smailyte, Eduardas Aleknavicius Rare types of breast Abstract: Breast cancer
More informationImage-guided core needle biopsy has become a standard
Pathologic Review of Atypical Hyperplasia Identified by Image-Guided Breast Needle Core Biopsy Correlation With Excision Specimen I-Tien Yeh, MD; Diana Dimitrov, MD; Pamela Otto, MD; Alexander R. Miller,
More informationAccess and take the CME test online and receive 1 AMA PRA Category 1 Credit at CME.TheOncologist.com
The Oncologist Breast Cancer Current Treatment and Clinical Trial Developments for Ductal Carcinoma In Situ of the Breast JUDY C. BOUGHEY, a RICARDO J. GONZALEZ, b EVERETT BONNER, c HENRY M. KUERER b a
More informationMaram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine
Maram Abdaljaleel, MD Dermatopathologist and Neuropathologist University of Jordan, School of Medicine The most common non-skin malignancy of women 2 nd most common cause of cancer deaths in women, following
More informationApocrine Mammary Carcinoma
Apocrine Mammary Carcinoma A Clinicopathologic Study of 72 Cases ANDREA D. ABATI, M.D., MAREK KIMMEL, PH.D., AND PAUL P. ROSEN, M.D. Apocrine carcinoma (AC) is an uncommon, poorly characterized type of
More informationThe 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach
The 2015 World Health Organization Classification for Lung Adenocarcinomas: A Practical Approach Dr. Carol Farver Director, Pulmonary Pathology Pathology and Laboratory Medicine Institute Objectives Discuss
More informationCase Scenario 1 History and Physical 3/15/13 Imaging Pathology
Case Scenario 1 History and Physical 3/15/13 The patient is an 84 year old white female who presented with an abnormal mammogram. The patient has a five year history of refractory anemia with ringed sideroblasts
More informationUpdate on 2015 WHO Classification of Lung Adenocarcinoma 1/3/ Mayo Foundation for Medical Education and Research. All rights reserved.
1 Our speaker for this program is Dr. Anja Roden, an associate professor of Laboratory Medicine and Pathology at Mayo Clinic as well as consultant in the Anatomic Pathology Laboratory and co-director of
More informationDifferences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy
Acta Oncologica ISSN: 0284-186X (Print) 1651-226X (Online) Journal homepage: http://www.tandfonline.com/loi/ionc20 Differences in outcome for positive margins in a large cohort of breast cancer patients
More informationThe Diagnosis and Management of Pre-invasive Breast Disease: Flat Epithelial Atypia Classification, Pathologic Features and Clinical Significance
The Diagnosis and Management of Pre-invasive Breast Disease: Flat Epithelial Atypia Classification, Pathologic Features and Clinical Significance The Harvard community has made this article openly available.
More informationPatients and Methods
Relationship Between the Size and Margin Status of Ductal Carcinoma In Situ of the Breast and Residual Disease Liang Cheng, Nadia K. Al-Kaisi, Nahida H. Gordon, Alison Y. Liu, Fadi Gebrail, Robert R. Shenk*
More informationQ&A. Fabulous Prizes. Collecting Cancer Data: Breast 4/4/13. NAACCR Webinar Series Collecting Cancer Data Breast
Collecting Cancer Data Breast NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this webinar
More informationCOMPANION MEETING BREAST. Auditorium 11:15 1:00 am. Convenor: A/Professor Gelareh Farshid, SA Pathology, SA
Australasian Division of the International Academy of Pathology Limited ABN 73 008 593 815 36 TH Annual Scientific Meeting Darling Harbour Convention Centre, Sydney, Australia June 3-5, 2011 COMPANION
More informationDivision of Oncology/Hematology, Department of Medicine, Winthrop-University Hospital, 200 Old Country Road, Suite 450, Mineola, NY 11501, USA 2
International Scholarly Research Network ISRN Oncology Volume 2011, Article ID 673790, 5 pages doi:10.5402/2011/673790 Clinical Study Study of Estrogen Receptor and Progesterone Receptor Expression in
More informationBreast Cancer. Most common cancer among women in the US. 2nd leading cause of death in women. Mortality rates though have declined
Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women Mortality rates though have declined 1 in 8 women will develop breast cancer Breast Cancer Breast cancer increases
More informationGood afternoon everyone. First of all many thanks to Dr. Bonaventura and Dr. Arn for inviting
PATHOLOGY IN-SITU CARCINOMA, ROHIT BHARGAVA, MD 1 Good afternoon everyone. First of all many thanks to Dr. Bonaventura and Dr. Arn for inviting me here, it s great to be here and I m going to talk about
More informationBreast Cancer. Saima Saeed MD
Breast Cancer Saima Saeed MD Breast Cancer Most common cancer among women in the US 2nd leading cause of death in women 1 in 8 women will develop breast cancer Incidence/mortality rates have declined Breast
More informationAccuracy of Intraoperative Frozen-Section Analysis of Breast Cancer Lumpectomy-Bed Margins
Accuracy of Intraoperative Frozen-Section Analysis of Breast Cancer Lumpectomy-Bed Margins Juan C Cendán, MD, FACS, Dominique Coco, MD, Edward M Copeland III, MD, FACS BACKGROUND: STUDY DESIGN: RESULTS:
More informationTable of contents. Page 2 of 40
Page 1 of 40 Table of contents Introduction... 4 1. Background Information... 6 1a: Referral source for the New Zealand episodes... 6 1b. Invasive and DCIS episodes by referral source... 7 1d. Age of the
More informationInvasive Papillary Breast Carcinoma
410 This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the
More information